Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
announced the market approval of QSYMIA ® (phentermine and topiramate extended-release capsules) CIV in the United Arab Emirates (UAE) for treatment of overweight and obesity in adults and ...
The episode will feature John Amos, Chief Executive Officer at VIVUS LLC, along with leading weight-loss experts, to discuss QSYMIA® (phentermine and topiramate extended-release capsules CIV ...
In response to the substantial health and economic burdens of the obesity epidemic, VIVUS is expanding access to Qsymia to patients in multiple European countries, which will be sold under the trade ...
QSYMIA may slow the increase in height in children 12 years and older. QSIVA (phentermine and topiramate modified-release) hard capsules is contraindicated in pregnancy and in women of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results